UBS Group
CNXC icon

UBS Group’s Concentrix CNXC Stock Holding History

UBS Group’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71M Buy
3,167,616
+879,754
+38% +$22.9M 0.01% 1413
2026
Q1 		$62.6M Buy
2,287,862
+1,919,052
+520% +$68.1M 0.01% 1417
2025
Q4 		$15.3M Sell
368,810
-69,837
-16% -$2.83M ﹤0.01% 2839
2025
Q3 		$20.2M Sell
438,647
-5,447
-1% -$291K ﹤0.01% 2547
2025
Q2 		$23.5M Buy
444,094
+47,259
+12% +$2.5M ﹤0.01% 2210
2025
Q1 		$22.1M Sell
396,835
-153,480
-28% -$7.35M ﹤0.01% 2215
2024
Q4 		$23.8M Buy
550,315
+515,698
+1,490% +$22.9M ﹤0.01% 2148
2024
Q3 		$1.77M Buy
34,617
+490
+1% +$32.8K ﹤0.01% 4123
2024
Q2 		$2.16M Buy
34,127
+5,401
+19% +$324K ﹤0.01% 3698
2024
Q1 		$1.9M Buy
28,726
+21,074
+275% +$1.71M ﹤0.01% 4002
2023
Q4 		$752K Buy
7,652
+4,361
+133% +$380K ﹤0.01% 4744
2023
Q3 		$264K Sell
3,291
-57,314
-95% -$4.5M ﹤0.01% 5172
2023
Q2 		$4.89M Buy
60,605
+57,112
+1,635% +$5.34M ﹤0.01% 2616
2023
Q1 		$425K Sell
3,493
-10,582
-75% -$1.44M ﹤0.01% 4817
2022
Q4 		$1.87M Buy
14,075
+10,999
+358% +$1.34M ﹤0.01% 3451
2022
Q3 		$343K Sell
3,076
-4,869
-61% -$623K ﹤0.01% 4662
2022
Q2 		$1.08M Sell
7,945
-4,385
-36% -$660K ﹤0.01% 3673
2022
Q1 		$2.05M Sell
12,330
-34,990
-74% -$6.64M ﹤0.01% 3394
2021
Q4 		$8.45M Buy
47,320
+17,566
+59% +$3.13M ﹤0.01% 2298
2021
Q3 		$5.27M Sell
29,754
-5,810
-16% -$963K ﹤0.01% 2619
2021
Q2 		$5.72M Buy
35,564
+19,885
+127% +$3.06M ﹤0.01% 2545
2021
Q1 		$2.35M Sell
15,679
-6,865
-30% -$832K ﹤0.01% 3401
2020
Q4 		$2.23M Buy
+22,544
New +$2.25M ﹤0.01% 3314

Other funds holding CNXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GBL
Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group's CNXC Position: Q2 2026 in Review

UBS Group increased its Concentrix (CNXC) stake by 38% in Q2 2026, buying an estimated $22.9M and bringing the position to 3,167,616 shares worth $71M. The position accounts for 0.01% of the portfolio, ranked #1413.

UBS Group first reported a position in CNXC in Q4 2020 and has held it in 23 quarters since. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • UBS Group held 3,167,616 shares of Concentrix worth $71M as of Q2 2026.
  • UBS Group bought 879,754 Concentrix shares in Q2 2026, an estimated $22.9M.
  • Concentrix made up 0.01% of UBS Group's portfolio in Q2 2026, its #1413 holding.
  • UBS Group first reported a position in Concentrix in Q4 2020 and has held it in 23 quarters since.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.